Dipeptidyl peptidases in human muscle disease.
With the use of selective inhibitors of arylamidase, four dipeptyl peptidases (I, II, III, and IV) capable of hydrolyzing the beta-naphthylamides of Gly-Arg, Lys-Ala, Arg-Arg and Gly-Pro, respectively, were distinguished in homogenates of human muscle. Dipeptidyl peptidase I showed maximum activity at pH 5.0-6.0. Dipeptidyl peptidase II was maximally active at pH 5.0 and inhibited by cations. Dipeptidyl peptidases III and IV were most active at pH 8.5 and 7.5, respectively. When compared to controls, significant increases in muscle dipeptidyl peptidases I and II were observed in patients with muscular dystrophies and polymyositis. Dipeptidyl peptidase III was not altered in the neuromuscular disease examined. Dipeptidyl peptidase IV showed marked increase in a variety of muscle wasting conditions. The increase in dipeptidyl peptidases I and II may be attributed to lysosomal activation that is known to occur in conditions of muscle degeneration. However, the striking increase in a variety of muscle diseases of dipeptidyl peptidase IV, an enzyme shown to be associated with microsomal membranes in other tissues, suggest that in addition to lysosomes other sources also contribute to the total hydrolytic potential of diseased muscles. Dipeptidyl peptidases II and IV were found to be present in human serum. Their levels were not altered in serum of patients with Duchenne dystrophy.
D004150:Dipeptidases / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D009132:Muscles / Q000201:enzymology*; D009135:Muscular Diseases / Q000201:enzymology*; D009136:Muscular Dystrophies / Q000201:enzymology; D009468:Neuromuscular Diseases / Q000201:enzymology*; D013379:Substrate Specificity
D004150:Dipeptidases